Jean‐Marc Rolain

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix‐Assisted Laser Desorption Ionization Time‐of‐Flight Mass Spectrometry

Piseth Seng, Michel Drancourt, Frédérique Gouriet et al. · Clinical Infectious Diseases · 2009 · 1.9K citations

Life Sciences, Microbiology, Molecular Biology +17

ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes

Sushim K. Gupta, Seydina M. Diene, Rafael López-Rojas et al. · Antimicrobial Agents and Chemotherapy · 2013 · 1.5K citations · Full text

Life Sciences, Bioinformatics, Microbiology +17

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Christian Devaux, Jean‐Marc Rolain, Philippe Colson et al. · International Journal of Antimicrobial Agents · 2020 · 1.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · medRxiv · 2020 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17